natgillin/translations-raw huggingface dataset:
In a 400 subject recurrent glioma data set, Grade 4 neutropenia occurred in 8 % of female vs 4 % of male subjects and Grade 4 thrombocytopenia in 8 % of female vs 3 % of male subjects in the first cycle of therapy. 
Po podatkih o ponavljajočem se gliomu pri 400 preiskovancih se je v prvem ciklu terapije nevtropenija 4. stopnje pojavila pri 8 % žensk in pri 4 % moških preiskovancev, trombocitopenija 4. stopnje pa pri 8 % žensk in 3 % moških preiskovancev.
The body is imprinted with “140”. 
Na telesu pa je vtisnjen znak „140”.
This adds up to a 28-day treatment cycle. 
To je skupaj 28 dni v enem ciklu zdravljenja.
In a separate pharmacokinetic study, plasma pharmacokinetic profiles in patients with mild to moderate hepatic impairment were similar to those observed in patients with normal hepatic function. 
V ločeni študiji farmakokinetike temozolomida so ugotavljali, da so plazemski farmakokinetični profili pri bolnikih z blago do zmerno jetrno okvaro podobni profilom pri bolnikih z normalnim delovanjem jeter.
Absolute neutrophil count 
Absolutno število nevtrofilcev
During the concomitant phase, your doctor will start Temozolomide Sandoz at a dose of 75 mg/m2 
Med fazo sočasnega zdravljenja vam bo zdravnik začel dajati zdravilo Temozolomid Sandoz v odmerku 75 mg/m2 (običajni odmerek).
Very rare cases of lung side effects have been observed with temozolomide. 
Pri temozolomidu so opazili zelo redke primere neželenih učinkov na pljučih.
Do not open, crush or chew the capsules. 
Kapsul ne smete odpirati, zdrobiti ali žvečiti.
Myelosuppression (neutropenia and thrombocytopenia), which is known dose-limiting toxicity for most cytotoxic agents, including TMZ, was observed. 
Opažali so mielosupresijo (nevtropenijo in trombocitopenijo), kar so znani toksični učinki večine citotoksičnih snovi, vključno s TMZ, ki tudi omejujejo njihov odmerek.
Dose during Cycles 2-6 in absence of toxicity 
Odmerek med 1. ciklom Odmerek med 2. in 6 ciklom brez toksičnosti
If a capsule is damaged, avoid contact of the powder with your skin, eyes or nose. 
Če se kapsula poškoduje, se izogibajte stiku praška s kožo, očmi ali nosom.
Patients will be carefully checked by their doctor for signs of this infection before treatment is started. 
Pred začetkom zdravljenja mora zdravnik natančno preveriti, ali ima bolnik znake te okužbe.
• wound infection 
• okužbe ran,
- absolute neutrophil count (ANC) ≥ 1.5 x 109/l 
- absolutno število nevtrofilcev (ANC - Absolute Neutrophil Count) ≥ 1,5 x 109/l,
• loss of weight 
• izguba teka,
≥ 0.5 and < 1.5 x 109/l 
≥ 0,5 in < 1,5 x 109/l
Oral TMZ has been studied in paediatric patients (age 3-18 years) with recurrent brainstem glioma or recurrent high grade astrocytoma, in a regimen administered daily for 5 days every 28 days. 
Peroralni TMZ so preučevali pri pediatričnih bolnikih (starih 3-18 let) s ponavljajočim se gliomom možganskega debla ali ponavljajočim se astrocitomom visoke stopnje, ki so zdravilo prejemali 5 dni, na vsakih 28 dni.
≥ 10 and < 100 x 109/l 
≥ 10 in < 100 x 109/l
• if you have ever had or might now have a hepatitis B infection. 
• če ste kdaj imeli ali imate okužbo z virusom hepatitisa B. Temozolomid namreč lahko povzroči reaktivacijo hepatitisa B, ki je lahko v nekaterih primerih usodna.
Edvard Thomsens Vej 14 DK-2300 København S 
Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S
If you have not been previously treated with chemotherapy, your first dose of Temozolomide Sandoz will be 200 mg/m2 once daily for the first 5 days. 
Če se v preteklosti niste zdravili s kemoterapijo, bo prvi odmerek zdravila Temozolomid Sandoz 200 mg/m2 enkrat na dan prvih 5 dni.
Hypokalemia, alkaline phosphatase increased, weight increased 
hipokaliemija, zvišanje vrednosti alkalne fosfataze, povečanje telesne mase hiperglikemija, povečanje telesne mase
Contact your doctor immediately if you have any of the following: 
Če imate katerega koli od naštetih znakov, nemudoma obvestite zdravnika:
The major route of 14C elimination is renal. 
Zdravilo 14C se izloča predvsem skozi ledvice.
cytomegalovirus infection, infection reactivation such as cytomegalovirus, hepatitis B virus†, meningoencephalitis herpetic†, Sepsis† 
okužba s citomegalovirusom, reaktivacija okužbe, npr. citomegalovirus, virus hepatitisa B†, herpetični meningoencefalitis†, sepsa†
TMZ dosing interruption or discontinuation during concomitant radiotherapy and TMZ 
Prekinitev jemanja ali ukinitev TMZ med sočasno radioterapijo in zdravljenjem s TMZ
In patients previously untreated with chemotherapy, TMZ is administered orally at a dose of 200 mg/m2 once daily for the first 5 days followed by a 23 day treatment interruption (total of 28 days). 
Bolniki, ki še niso bili zdravljeni s kemoterapijo, naj jemljejo TMZ peroralno v odmerku 200 mg/m2 enkrat na dan prvih 5 dni, temu pa naj sledi 23-dnevni premor (skupaj 28 dni).
CTC Grade 3 or 4 
SMT 3. ali 4. stopnje a:
Then, you will start the monotherapy phase. 
Nato se bo začela faza zdravljenja z enim zdravilom.
CTC Grade 4b a: TMZ dose levels are listed in Table 2. b: TMZ is to be discontinued if: 
SMT 4. stopnjab a: Ravni odmerkov TMZ so podane v preglednici 2.
This medicine is an antitumour agent. 
To je zdravilo proti tumorjem.
Colour of the cap 
Barva ovojnice
In patients with prior chemotherapy a benefit was indicated in those with a KPS ≥ 80. 
Pri bolnikih, ki so že prejemali kemoterapijo, so ugotavljali koristne učinke zdravila pri bolnikih z indeksom kliničnega stanja po Karnofskyju ≥ 80.
a: Treatment with concomitant TMZ can be continued when all of the following conditions are met: absolute neutrophil count ≥ 1.5 x 109/l; thrombocyte count ≥ 100 x 109/l; CTC non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea, vomiting). 
Sočasno zdravljenje s TMZ lahko nadaljujete, če so izpolnjeni vsi od naslednjih pogojev: absolutno število nevtrofilcev ≥ 1,5 x 109/l; število trombocitov ≥ 100 x 109/l; SMT za nehematološko toksičnost ≤ 1. stopnje (z izjemo alopecije, slabosti in bruhanja).
Somnolence, dizziness, paresthesia 
zaspanost, omotica, parestezije
Each capsule is approximately 15.8 mm in length. 
Dolžina ene kapsule je približno 15,8 mm.
Bottle 
Steklenica
Therefore, men being treated with it should be advised not to father a child up to 6 months after receiving the last dose and to seek advice on cryoconservation of sperm prior to treatment, because of the possibility of irreversible infertility due to therapy with TMZ. 
TMZ ima lahko genotoksične učinke, zato morate moškim, ki se zdravijo z njim svetovati, naj ne zaplodijo otroka še šest mesecev po zadnjem vzetem odmerku in naj se zaradi možnosti ireverzibilne neplodnosti zaradi zdravljenja s TMZ pred zdravljenjem posvetujejo o možnostih shranjevanja zamrznjene sperme.
No data are available on the administration of TMZ in patients with severe hepatic impairment (Child's Class C) or with renal impairment. 
Podatki o uporabi TMZ pri bolnikih s hudo jetrno okvaro (razred C po
Concomitant phase 
Faza sočasne terapije
≥ 100 x 10 
≥ 10 in < 100 x 10
Cerebral haemorrhage, hypertension Embolism pulmonary, oedema, oedema peripheral 
možganske krvavitve, hipertenzija pljučna embolija, edem, periferni edem
New or reactivated (recurring) cytomegalovirus infections and reactivated hepatitis B virus infections have been uncommonly reported. 
Občasno so poročali o novih ali reaktiviranih (ponovljenih) okužbah s citomegalovirusom in o reaktiviranih okužbah z virusom hepatitisa B. Občasno so poročali o primerih možganskih okužb, ki jih povzroča herpesvirus (herpetični meningoencefalitis), vključno s smrtnimi primeri.
Micturition frequency, urinary incontinence Urinary incontinence 
pogosto uriniranje, inkontinenca seča inkontinenca seča
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare 
zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do
Very common: 
Zelo pogosti:
The bottles also contain a desiccant pouch. 
Steklenica vsebuje tudi zavojček sušilnega sredstva.
positions of guanine. 
- Navodilo shranite.
After oral administration of 14C-labelled TMZ, mean faecal excretion of 14C over 7 days post-dose was 0.8 % 
Po peroralnem jemanju TMZ, označenega s 14C, je bila srednja vrednost količine 14C, izločene v blatu 7 dni po odmerku
• difficulty controlling your bowel movements 
• težave z nadzorovanjem odvajanja blata,
INSTRUCTIONS ON USE 
B. NAVODILO ZA UPORABO
What Temozolomide Sandoz looks like and contents of the pack 
Izgled zdravila Temozolomid Sandoz in vsebina pakiranja
This may cause you to have increased bruising or bleeding, anaemia (a shortage of red blood cells), fever, and reduced resistance to infections. 
(pomanjkanje rdečih krvnih celic), zvišana telesna temperatura in zmanjšana odpornost proti okužbam.
• impaired coordination 
• motnje koordinacije,
However, all patients receiving TMZ, particularly patients receiving steroids, should be observed closely for the development of PCP, regardless of the regimen. 
Pri uporabi TMZ v okviru daljšega režima zdravljenja lahko pride do večje pogostnosti PCP, vendar morate vse bolnike, ki prejemajo zdravilo TMZ, še posebej tiste, ki prejemajo tudi steroide, skrbno opazovati, da ugotovite morebiten pojav PCP, ne glede na režim zdravljenja.
Abdominal distension, fecal incontinence, gastrointestinal disorder (NOS), gastroenteritis, haemorrhoids 
napihnjenost trebuha, inkontinenca blata, bolezni prebavil (NOS), gastroenteritis, hemoroidi
Adverse reactions in patients with recurrent or progressive malignant glioma 
Neželene reakcije pri bolnikih s ponavljajočim se ali napredujočim malignim gliomom
CSF penetration was confirmed in one patient; CSF exposure based on AUC of TMZ was approximately 30 % of that in plasma, which is consistent with animal data. 
za TMZ, je bila približno 30 % tiste v plazmi, kar je v skladu s podatki, ki so jih dobili pri živalih.
The following additional serious adverse reactions have been identified during post-marketing exposure: 
V obdobju trženja zdravila so ugotovili dodatne resne neželene učinke, in sicer:
Response rate, based on the central reviewer assessment, was 35 % (13 CR and 43 PR) for the intent-to-treat population (ITT) n=162. 
Po ugotovitvi osrednjega ocenjevalca je bil delež odziva v populaciji, ki so jo želeli zdraviti (ITT, n=162) 35 % (13
Agitation, apathy, behaviour disorder, depression, hallucination 
vznemirjenost, apatija, vedenjske motnje, depresija, halucinacije halucinacije, amnezija
• reduced number of blood cells (neutropenia, thrombocytopenia, lymphopenia, leukopenia) 
• zmanjšano število krvnih celic (nevtropenija, trombocitopenija, limfopenjia, levkopenija),
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING SACHETS 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA, KI VSEBUJE VREČKO
Cases of fatal respiratory failure have been reported in patients using TMZ, in particular in combination with dexamethasone or other steroids. 
Pri bolnikih, ki prejemajo TMZ, zlasti v kombinaciji z deksametazonom ali drugimi steroidi, so poročali o respiratorni odpovedi s smrtnim izidom.
Opportunistic infections and reactivation of infections Opportunistic infections (such as Pneumocystis jirovecii pneumonia) and reactivation of infections (such as HBV, CMV) have been observed during the treatment with TMZ (see section 4.8). 
Pneumocystis jirovecii) in reaktivacijo okužb (npr. HBV, CMV) (glejte poglavje 4.8).
• confusion 
• zmedenost,
• breast pain 
• trebušne bolečine,
Pneumonia, sinusitis, upper respiratory infection, bronchitis 
kongestija nosne sluznice pljučnica, sinusitis, okužba zgornjih dihal, bronhitis
Remarks Reduction for prior toxicity Dose during Cycle 1 Dose during Cycles 2-6 in absence of toxicity Table 3. 
Odmerek med 1. ciklom Odmerek med 2. in 6. ciklom brez toksičnosti
Skin and subcutaneous tissue disorders 
Bolezni kože in podkožja
Anti-emetic therapy 
Antiemetično zdravljenje
If you have been previously treated with chemotherapy, your first dose of Temozolomide Sandoz will be 150 mg/m2 once daily for the first 
Če ste se v preteklosti zdravili s kemoterapijo, bo prvi odmerek zdravila Temozolomid Sandoz 150 mg/m2 enkrat na dan prvih 5 dni.
Hepatic injury, including fatal hepatic failure, has been reported in patients treated with TMZ (see section 4.8). 
Pri bolnikih, zdravljenih s TMZ, so poročali o poškodbah jeter, vključno z odpovedjo jeter s smrtnim izidom (glejte poglavje 4.8).
• severe headache that does not go away. 
• hud neprekinjen glavobol.
• inability to fall asleep or stay asleep 
• nezmožnost zaspati ali zbujanje ponoči, • občutek mravljincev,
Metabolism and nutrition disorders Very common: 
Presnovne in prehranske motnje Zelo pogosti:
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01AX03 Mechanism of action 
Farmakoterapevtska skupina: Antineoplastična zdravila - Drugi alkilirajoči citostatiki, oznaka ATC:
Reduction for prior toxicity Dose during Cycle 1 
Zmanjšanje zaradi prejšnje toksičnosti
The body is imprinted with “100”. 
Na telesu pa je vtisnjen znak „100”.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION 
POSTOPEK IN POT(I) UPORABE ZDRAVILA
Cytotoxic lesions that develop subsequently are thought to involve aberrant repair of the methyl adduct. 
V nastanek citotoksičnih lezij je verjetno vpletena motnja mehanizmov za popravilo metilnih aduktov.
• how many capsules you need to take every dosing day. 
Pomembno je, da v celoti razumete ali si zapomnite naslednje: • koliko kapsul morate vzeti vsak dan jemanja.
• pneumonia 
• pljučnica,
Novartis (Hellas) S.A.C.I 18, Kifisias Ave. & Gyzi, 151 25 Marousi, Athens Τηλ: +30 216 6005011 regulatory.greece@sandoz.com 
Novartis (Hellas) S.A.C.I 18, Kifisias Ave. & Gyzi, 151 25 Marousi, Athens
You might be more prone to infections, bruising or bleeding. 
• če ste starejši od 70 let, boste bolj dovzetni za okužbe, modrice ali krvavitve.
Convulsions were reported very commonly in the newly-diagnosed glioblastoma multiforme patients receiving monotherapy, and rash was reported very commonly in newly-diagnosed glioblastoma multiforme patients receiving TMZ concurrent with RT and also as monotherapy, and commonly in recurrent glioma. 
Pri bolnikih z novo diagnosticiranim multiformnim glioblastomom na monoterapiji so zelo pogosto poročali o konvulzijah, medtem ko je bil izpuščaj opisan zelo pogosto pri bolnikih z novo diagnosticiranim multiformnim glioblastomom, ki so prejemali TMZ sočasno z RT, ter pri tistih, ki so zdravilo prejemali v obliki monoterapije, pogosto pa pri tistih s ponavljajočim se gliomom.
• swollen stomach 
• napihnjenost želodca,
You will take Temozolomide Sandoz alone once daily for the first 5 days. 
Prvih 5 dni boste jemali samo zdravilo Temozolomid Sandoz enkrat na dan.
• discolouration of your tongue 
• drgetanje, • obarvanje jezika,
• inflammation of your sinuses 
• vnetje sinusov,
Nausea and vomiting are very commonly associated with TMZ. 
Z jemanjem TMZ sta zelo pogosto povezana slabost in bruhanje.
Hyperglycaemia, weight increased 
hiperglikemija, hujšanje hujšanje
• in adults with newly-diagnosed glioblastoma multiforme. 
• pri odraslih bolnikih z novo diagnosticiranim multiformnim glioblastomom.
Hemianopia, visual acuity reduced, vision disorder, visual field defect, eye pain 
hemianopija, zmanjšana ostrina vida, motnje vida, izpad vidnega polja, očesne bolečine zmanjšana ostrina vida,
• if certain kinds of blood cells are severely reduced (myelosuppression), such as your white blood cell count and platelet count. 
• če imate močno zmanjšano število določenih vrst krvnih celic (mielosupresija), kot na primer število levkocitov ali trombocitov.
Muscle weakness, arthralgia, musculoskeletal pain, myalgia 
mišična šibkost, artralgija mišična šibkost, artralgija, mišičnoskeletne bolečine,
TMZ dose levels for monotherapy treatment 
Ravni odmerkov TMZ za monoterapijo Raven odmerka
General disorders and administration site conditions Very common: 
Splošne težave in spremembe na mestu aplikacije Zelo pogosti:
TMZ dose reduction or discontinuation during monotherapy treatment Toxicity 
Zmanjšanje odmerka ali ukinitev zdravila TMZ med monoterapijo
• abnormal or blurry vision 
• nenormalen ali zamegljen vid,
Each hard capsule contains 131.4 mg of anhydrous lactose. 
Ena trda kapsula vsebuje 131,4 mg brezvodne laktoze.
Each hard capsule contains 73 mg of anhydrous lactose. 
Ena trda kapsula vsebuje 73 mg brezvodne laktoze.
Recurrent or progressive malignant glioma 
Ponavljajoči se ali napredujoči maligni gliom
• reduced number of blood cells (neutropenia or lymphopenia, thrombocytopenia) 
• zmanjšano število krvnih celic (nevtropenija ali limfopenija, trombocitopenija),
Skin and subcutaneous tissue disorders Common: 
Bolezni kože in podkožja Common:
9/l, and the thrombocyte count is ≥ 100 x 109/l. 
9/l in število trombocitov ≥ 100 x 10
If vomiting occurs after the dose is administered, a second dose should not be administered that day. 
Če po zaužitju odmerka bruha, ne sme še isti dan vzeti drugega odmerka.
Most haematologic adverse reactions were reported commonly or very commonly in both indications (Tables 4 and 5); the frequency of grade 3-4 laboratory findings is presented after each table. 
Pri obeh indikacijah so o večini hematoloških neželenih reakcij poročali pogosto ali zelo pogosto (preglednici 4 in 5).
Each capsule is approximately 21.4 mm in length. 
Dolžina ene kapsule je približno 21,4 mm.
In post marketing cases, meningoencephalitis herpetic (including fatal cases) has been observed in patients receiving TMZ in combination with radiotherapy, including cases of concomitant steroids administration. 
V obdobju trženja so pri bolnikih, ki so prejemali TMZ v kombinaciji z radioterapijo, vključno s primeri sočasnega dajanja steroidov, opazili primere herpetičnega meningoencefalitisa (vključno s smrtnimi primeri).
CTC non-haematological Toxicity (except for alopecia, nausea, vomiting) 
SMT za nehematološko toksičnost (z izjemo alopecije, slabosti in bruhanja)
Each capsule is approximately 11.4 mm in length. 
Dolžina ene kapsule je približno 11,4 mm.
CTC non-haematological toxicity (except for alopecia, nausea, vomiting) CTC Grade 2 
SMT za nehematološko toksičnost (z izjemo alopecije, slabosti in bruhanja) SMT 2. stopnje
Myopathy, back pain, musculoskeletal pain, myalgia 
miopatija, bolečine v hrbtu, mišičnoskeletne bolečine,
• constipation (difficulty passing stools) 
• zaprtje (težko odvajanje blata),
Table 4 provides treatment-emergent adverse events in patients with newly-diagnosed glioblastoma multiforme during the concomitant and monotherapy phases of treatment. 
V preglednici 4 so navedeni neželeni učinki, ki so nastopili med zdravljenjem pri bolnikih z novo diagnosticiranim multiformnim glioblastomom med fazo sočasne terapije in fazo monoterapije.
23 %, respectively. 
posnetkov, je bila 8 %.
If you accidentally take more Temozolomide Sandoz capsules than you were told to, contact your doctor, pharmacist or nurse immediately. 
Če ste vzeli večji odmerek zdravila Temozolomid Sandoz, kot bi smeli Če pomotoma vzamete preveč kapsul Temozolomid Sandoz, se takoj posvetujte zdravnikom,
Patients treated with TMZ may experience myelosuppression, including prolonged pancytopenia, which may result in aplastic anaemia, which in some cases has resulted in a fatal outcome. 
Pri bolnikih, zdravljenih s TMZ, lahko pride do mielosupresije, vključno s podaljšano pancitopenijo.
(≥1/10,000 to <1/1,000); Very rare (<1/10,000)), Not known: frequency cannot be estimated from the available data. 
<1/1.000), zelo redki (<1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Skin and subcutaneous tissue disorders Very common: 
Bolezni kože in podkožja Zelo pogosti:
A total of 573 patients were randomised to receive either TMZ + RT (n=287) or RT alone (n=286). 
Novo diagnosticirani multiformni glioblastom Skupaj 573 bolnikov so randomizirali v dve skupini, od katerih je ena prejemala TMZ in RT (n=287),
Each capsule is approximately 19.3 mm in length. 
Dolžina ene kapsule je približno 19,3 mm.
The median PFS was 5.4 months. 
Mediana vrednost časa brez napredovanja bolezni je bila 5,4 mesece.
There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death. 
Obstajajo poročila o bolnikih, ki so jemali priporočeni odmerek dlje kot 5 dni zdravljenja (do 64 dni).
Each hard capsule contains 14.6 mg of anhydrous lactose. 
Ena trda kapsula vsebuje 14,6 mg brezvodne laktoze.
• oral infections 
• okužbe v ustni votlini,
Haemorrhage, oedema, oedema leg Haemorrhage, deep venous thrombosis, oedema leg 
krvavitve, edem, edem nog krvavitve, globoka venska tromboza, edem nog
Very common (may affect more than 1 in 10 people): 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov):
Newly-diagnosed glioblastoma multiforme 
Novo diagnosticiranmultiformni glioblastom
Then, you will have 23 days without Temozolomide Sandoz. 
Nato bo sledilo 23-dnevno obdobje, v katerem zdravila Temozolomid Sandoz ne boste jemali.
Very rare (may affect up to 1 in 10,000 people): 
Zelo redki (pojavijo se lahko pri naveč 1 od 10.000 bolnikov):
Patients with hepatic or renal impairment The pharmacokinetics of TMZ were comparable in patients with normal hepatic function and in those with mild or moderate hepatic impairment. 
Pri bolnikih z blago ali zmerno jetrno okvaro je farmakokinetika TMZ podobna kot pri tistih z normalnim delovanjem jeter.
Headache 
glavobol
Rare (may affect up to 1 in 1,000 people): 
Redki (pojavijo se lahko pri največ 1 od 1.000 bolnikov):
Grade 3 or Grade 4 thrombocyte abnormalities, including thrombocytopenic events were observed in 14 % of the patients who received TMZ. 
Anomalije trombocitov 3. ali 4. stopnje, vključno s trombocitopeničnimi sopojavi, so opažali pri 14 %
The bottles contain a desiccant pouch. 
Steklenica vsebuje zavojček sušilnega sredstva.
Skin exfoliation, photosensitivity reaction, pigmentation abnormal 
luščenje kože, preobčutljivostne reakcije na svetlobo, nenormalna pigmentacija eritem, nenormalna pigmentacija,
Always take Temozolomide Sandoz exactly as your doctor has told you. 
Pri jemanju zdravila Temozolomid Sandoz natančno upoštevajte navodila zdravnika.
Myopathy, back pain 
mialgija miopatija, bolečine v hrbtu
• painful joints 
• boleči sklepi,
Each hard capsule contains 168 mg of anhydrous lactose. 
Ena trda kapsula vsebuje 168 mg brezvodne laktoze.
Stomatitis, diarrhoea, dyspepsia, dysphagia, mouth dry 
stomatitis, driska, trebušne bolečine, dispepsija, disfagija stomatitis, driska, dispepsija, disfagija, suha usta
Anxiety, emotional lability, insomnia Anxiety, depression, emotional lability, insomnia 
zaskrbljenost, čustvena nestabilnost, nespečnost zaskrbljenost, depresija, čustvena nestabilnost, nespečnost
Hemiparesis, aphasia, balance impaired, somnolence, confusion, dizziness, memory impairment, concentration impaired, dysphasia, neurological disorder (NOS), neuropathy, peripheral neuropathy, paresthesia, speech disorder, tremor 
konvulzije, motnje zavesti, somnolenca, afazija, motnje ravnotežja, omotica, zmedenost, motnje spomina, zmanjšanje miselne zbranosti, nevropatija, parestezije, motnje govora, tremor hemipareza, afazija, motnje ravnotežja, somnolenca, zmedenost, omotica, motnje spomina, zmanjšanje miselne zbranosti, disfazija, nevrološke motnje (NOS), nevropatija, periferna nevropatija, parestezije, motnje govora, tremor
Method of administration Temozolomide Sandoz hard capsules should be administered in the fasting state. 
Način uporabe Temozolomid Sandoz trde kapsule mora bolnik jemati na tešče.
Temozolomide Sandoz hard capsules should be administered in the fasting state. 
Temozolomid Sandoz trde kapsule mora bolnik jemati na tešče.
Printing ink 
Črnilo tiska:
Asthenia, face oedema, pain, condition aggravated, rigors, tooth disorder 
Astenija, edem obraza, bolečine, navali vročine, poslabšanje stanja, drgetanje, bolezni zob
Temozolomide Sandoz contains a medicine called temozolomide. 
Temozolomid Sandoz vsebuje zdravilno učinkovino temozolomid.
Each hard capsule contains 182.5 mg of anhydrous lactose. 
Ena trda kapsula vsebuje 182,5 mg brezvodne laktoze.